Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Owen Scott Muir · Said 15 Jan 2026 · owen-2053

Quote

Third-party claim

“not only is KetaFree submitted to the FDA to be approved as an on-label ketamine treatment”
· FDA-Approved Breakthrough! Neurolief Brings ProLivᵀᴹ Rx to the World! · substack post

RAMHT-AI 2026 recap. Jonathan Javitt (CEO, NRx) announced that KetaFree has been submitted to the FDA for approval as an on-label ketamine treatment. Regulatory pipeline item; no outcome asserted by the author.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.

← Earlier · Later → · All statements